Please login to the form below

Not currently logged in
Email:
Password:

Adrian Hodges appointed by GSK

Adrian Hodges is joining GlaxoSmithKline as vice president of its corporate responsibility and community partnerships function

Adrian Hodges is joining GlaxoSmithKline (GSK) as vice president of the firm's corporate responsibility and community partnerships function.

Hodges joins GSK from the International Business Leaders Forum (IBLF) where he has worked since 1997, and was most recently manager director. He joins GSK in March and will report to the senior vice president for global communications, Duncan Learmonth.

Commenting on his appointment, Hodges told the IBLF: "under the leadership of CEO Andrew Witty, the company has publicly declared that it wants to build trust with stakeholders as it discharges its responsibilities."

He continued: "My role will be to build on the great work the current team have put in place and to support the company's leadership in realising ambitious business objectives in line with a focused business strategy."

Learmonth said: "Adrian brings broad experience to the company including multiple external perspectives on integrating corporate responsibility into the business. He will play a pivotal role in continuing to build GSK's relationship with society as we seek to be more open, more flexible and more transparent in how we operate our business."

16th February 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics